Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force
Josef S Smolen(Medical University of Vienna), Désirée van der Heijde(Leiden University Medical Center)
Cited by 675
Related Papers
Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial
|The Lancet|2004|1.8k
Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: Two‐year clinical and radiographic results from the TEMPO study, a double‐blind, randomized trial
|Arthritis & Rheumatism|2006|542
EULAR definition of difficult-to-treat rheumatoid arthritis
|Annals of the Rheumatic Diseases|2020|538
EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis
|Annals of the Rheumatic Diseases|2021|273
ASAS/WHO ICF Core Sets for ankylosing spondylitis (AS): how to classify the impact of AS on functioning and health
|Annals of the Rheumatic Diseases|2009|138